Prawo i regulacje · 13/12/2023

DEA Proposes Scheduling of 2,5-Dimethoxy-4-Chloroamphetamine (DOC) and 2,5-Dimethoxy-4-Iodoamphetamine (DOI) as Schedule I Controlled Substances

The Drug Enforcement Administration is proposing to add 2,5-dimethoxy-4-chloroamphetamine (DOC) and 2,5-dimethoxy-4-iodoamphetamine (DOI) to Schedule I of the Controlled Substances Act, a move aimed at fulfilling U.S. obligations under the 1971 Convention on Psychotropic Substances, in order to regulate the handling and distribution of these substances.